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PREFACE
A new A/H1N1 influenza virus strain was officially reported/identified in Mexico
City on April 13 2009 and over a period of two-weeks the WHO pandemic alert was
moved from level 3 to level 5. By May 2, a total of 141 cases had been confirmed in
19 states across the USA. Additional cases were soon confirmed in fifteen countries
in Europe, Canada, New Zealand, and Asia. The global reach of this novel strain
became evident when a summer influenza incidence high was reached in Japan by
May 16, 2009 [2, 4] just about a month after its identification in the New World.
Efforts to identify the origin of the 2009 A/H1N1 novel virus strain engaged sev-
eral scientists immediately[5, 6]. Preliminary reports identified similarities between
the 2009 and the 1918 H1N1 influenza pandemics [1]. Most of the relatedness ar-
guments were based on the reported age-distribution of severe cases since a large
percentage of them seemed to involve young adults [3, 8, 7, 10]. The 1918 A/H1N1
outbreaks (we were reminded, often even by the press) were followed by a second
“wave”, the first driven by what appeared to be a mild strain in the spring and a
more virulent strain outbreak in the fall [8, 9].
The importance of implementing policies to mitigate the impact of the 2009
pandemic was pressing. We were aware that the second 1918 A/H1N1 waves were
responsible for a large percentage of the influenza-related deaths (over 90% accord-
ing to some reports). Whether or not the final course of the 2009 pandemic would
match or even resemble the patterns of the 1918-1920 (“Spanish influenza”), or
the 1957-1959 (Asian influenza), or the 1968-1970 (Hong Kong influenza) pandemic
outbreaks was not known but the potential raised valid concerns that had to be
addressed by policy makers under high levels of uncertainty. The predictions of a
severe second wave did not materialize. In fact, the second wave in Canada, while
much bigger than the first, was indeed milder [14] and that was a good thing.
By the start of 2010, it had become evident that this pandemic belonged to the
mild category to the point that its impact began to be compared to past seasonal
influenza outbreaks. Clearly, some of the elements of the WHO pandemic definition
turned out to be insufficient since for example, they did not incorporate measures
of disease severity. In fact, the WHO definition seemed to be primarily based on the
ability of the virus to invade susceptible populations at a global scale. The WHO
pandemic definition was put under the microscope. It should clearly be revised.
The limitations of WHOs pandemic definition have now been quantified at a
level of resolution that exceeds those used to evaluate past pandemics. The issue of
severity has entered into the analysis. Seasonal influenza, for example, is reported
to be responsible for about 35,000 deaths during the winter season in the US alone
with the majority of the victims being infants and the elderly [11]. Consequently,
the risk associated with this pandemic is being measured in relation to the average
severity of past “seasonal” influenza outbreaks. The mildness of this pandemic
seemed to have already been factored in by theoreticians who were asked to forecast
its consequences. Time reported just about a year ago that: “Marc Lipsitch, an
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epidemiologist at the Harvard School of Public Health, and his colleagues studied
the course of the 2009 H1N1 pandemic last spring in two cities New York and
Minneapolis and determined that 0.048% of people who developed symptoms of
H1N1 died, and 1.44% required hospitalization. Based on that data, published in
PLoS Medicine, Lipsitch anticipates far fewer deaths from 2009 H1N1 than was
initially believed. By the end of the flu season in the spring of 2010, Lipsitch
predicts, anywhere from 6,000 to 45,000 people will have died from H1N1 in the U.S.,
with the number most likely to end up between 10,000 and 15,000. Those estimates
are far below the death toll of the 1957 flu, which killed 69,800 people in the U.S.,
according to government figures, and smaller also than the early predictions for the
2009 H1N1 flu deaths, which ranged from 30,000 to 90,000.”
The official public health responses to what turned out to be a mild pandemic
brought into light the limitations and/or deficiencies of local, national, regional,
and global response policies. Using a hurricane analogy, it became obvious that,
while we should always hope for a “Rita” we must be prepared for a “Katrina”.
The current successes in mitigating the impact of seasonal influenza (vaccine, an-
tiviral drugs, and improved health practices and services) brought back additional
concerns. For example, the potential indiscriminate global use of antiviral drugs
not only provides additional opportunities for selection [13] but in fact, it is quite
possible that its overuse or over prescription, in times of uncertainty, may acceler-
ate it. Increases in the levels of drug resistance could make an important line of
defense not only less effective but potentially useless. The lack of a global policy re-
sponding effectively to global health emergencies is evident particularly when these
challenges are seen from a global perspective that considers influenzas responses to
evolutionary pressures [15, 16].
The collection of articles in this volume explores some of the consequences of poli-
cies constrained by the limited ability to respond effectively (levels of preparedness)
to the A/H1N1 2009 pandemic at a global scale. The volume highlights challenges
and opportunities that need to be addressed jointly by the scientific and public
health communities. Questions raised include: How useful has our knowledge of
past pandemics been in dealing with this global outbreak? What is our current
state of preparedness? How do we manage a limited supply of antiviral drugs or
vaccines? What is the impact of mass transformation systems (air-traffic and other)
on influenza dynamics? What are the lessons learned from observed international
mitigating efforts? How should severity be factored in the definition of a pandemic?
Soon after the onset of the 2009 influenza pandemic in Mexico, a group of bio-
statisticians, mathematicians, and public health officials primarily from Canada,
Mexico and the United States gathered in Tempe Arizona at a four-day workshop
in June 25-28, 2009. These researchers looked closely at incoming pandemic data
while introducing models to assess its impact. The driving goal of this effort has
been to identify ways of assessing the magnitude and mitigating the impact of this
pandemic. At the 2009 SIAM annual meeting (July 7-9, 2009), a special session was
held by members of this group. A meeting involving a large number of international
influenza researchers, was subsequently held in Vancouver, Canada (September 14-
16, 2009).
The contributions of some of the scientists that participated in these gatherings
are collected in this volume. They form the basis for the discussions that will
take place at the Centro Internacional de Ciencias, Cuernavaca, Mexico, in January
9-16, 2011. Scientists from Canada, Mexico and the USA will meet to evaluate
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what has been learned over the past 18 months. Researcher will use this meeting
to re-energize transnational collaborations on the study of the transmission and
evolutionary dynamics of influenza. It is the expectation that these efforts will
be carried out in collaboration with public health officials of these three nations.
The volume provides a self-contained collection of articles that serves at least two
purposes: (i) highlight the research driven by this recent influenza pandemic and
(ii) provide a centralized collection of contributions aimed at a wide community of
young researchers interested in the study of influenza epidemics.
In the first paper, Arino et al. provide an overview of mathematical model-
ing of the spread of infectious diseases with a focus on applications to pandemic
influenza. The authors discuss lessons learned and key insights from the applica-
tion of mathematical modeling to epidemic spread and “the complications arising
from attempts to apply it for disease outbreak management in a real public health
context.” Herrera-Valdez et al. identify potential mechanisms responsible for the
three “waves” observed in the A/H1N1 Mexico data. These researchers explore the
role of mass-regional transportation systems and government mandated or natu-
rally initiated social distancing measures on the generation of Mexico´s incidence
influenza patterns throughout 2009. The relative minimal impact of a late arriving
vaccine is also discussed. Nishiura´s contribution focuses on a pandemic that “offers
an opportunity to jointly quantify transmission dynamics and diagnostic accuracy
via a joint estimation procedure that exploits parsimonious models to describe the
epidemic dynamics and that parameterizes the number of test positives and test
negatives as a function of time.” The method is first shown to be effective if used
against 2007-2008 A (H1N1) Japanese data and then it is put to work on 2009
Tokyo-Narita airport screening data. The value of reporting both test positive and
test negative cases consistently is highlighted.
Reichert starts from the premise that current “Specific recommendations for
protection [US population] embody a bunker mentality with a time horizon of two
weeks, emulating preparation for a natural disaster. The epidemiology of pandemic
influenza is scarcely considered.” Reichert discusses the feasibility of protecting
institutions (within a society or community) against a disease introduction with
widespread levels of severe infections, that is, the type of scenario attached to in-
fluenza pandemics of high levels of severity. Reichert focuses on scenarios where only
the rigorous implementation of sequestration-in-place regimens coupled with decon-
tamination and quarantine procedures for re-entry together with wearing barrier
protection in the external world may avert catastrophes. In other words, Reichert
addresses social disruption dynamics as a function of pandemic severity.
The unavailability of a vaccine at the start of this pandemic provides ample proof
of the world´s inability to produce the substantial number of dosages needed to pro-
tect against pandemic influenza from a global perspective. Roy Curtiss III, a world
expert in the design, construction and evaluation of genetically modified recombi-
nant attenuated Salmonella vaccines administered intranasally or orally brings to
the forefront the challenges and opportunities for modelers raised by the efforts of
his group to develop vaccines that prevent infections by Streptococcus pneumoniae,
Mycobacterium tuberculosis, human and avian influenza and other diseases. In
addition to describing major infectious diseases and the current status for control
by vaccination, Roy Curtiss III also discussed the barriers to infection and the at-
tributes of innate and acquired immunity contributing to control. Moreover, the
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evolution in types of vaccines is presented in the context of developing technolo-
gies and in improving adjuvants to engender enhanced vaccine efficacy. The special
concerns and needs in vaccine design and development are also discussed in dealing
with epidemics/pandemics with special emphasis on influenza and current global
problems in vaccine delivery.
At the population level the question of who should be vaccinated first in the
absence of unlimited supplies or delays in delivery needs to be addressed. Should
we first vaccinate those with high-risk complications or individuals that must be
protected so that we have a functioning society? The world´s limited capacity to
produce enough A (H1N1) vaccines made the decisions taken during the past pan-
demic difficult. Further, delays in vaccine development, production and delivery
made it nearly impossible to respond effectively in a timely manner. Furthermore,
in a highly heterogeneous world, these decisions had to be made under different
constraints. Shim introduces an age/risk- structured model of influenza transmis-
sion parameterized with epidemiological data from the 2009 influenza A (H1N1)
pandemic. Her model predicts that the impact of vaccination would be dimin-
ished substantially if delays prevent timely access to an adequate vaccine supply.
“Nonetheless, prioritizing limited H1N1 vaccine to individuals with a high risk of
complications, followed by school-age children, and then preschool-age children,
would minimize an over- all attack rate as well as hospitalizations and deaths.”
Bowman et al. use an epidemic model to study the effects of single and two-dose
vaccination strategies on disease dynamics. They show, for example, “that, if vac-
cination starts early enough after the onset of the outbreak, a two-dose strategy
can lead to a greater reduction in the total number of infections” as long as the
second dose confers a substantially higher protection than the first dose. Knipl et
al observe “Finding optimal policies to reduce the morbidity and mortality of the
ongoing pandemic is a top public health priority.” They proceed to introduce a
compartmental model with age structure that keeps track of the vaccination status.
These authors examine “the effect of age specific scheduling of vaccination during
a pandemic influenza outbreak, when there is a race between the vaccination cam-
paign and the dynamics of the pandemic.” They conclude their study through a
careful assessment of the issues of timing and age-specific vaccination policies.
The identification of public health policies that minimize the relative cost of in-
terventions resulted in three contributions that apply optimal control theory two
three distinct scenarios derived from what was observed during the 2009 A (H1N1)
pandemic. Prosper at al. focus on the challenges faced by communities dealing si-
multaneously seasonal and novel A-H1N1 co-circulating strains outbreaks. Prosper
et al.´s study is carried out in an environment where individuals have no access
to novel A-H1N1 vaccine supplies, a limited access to a seasonal influenza vaccine
supply, and a limited supply of antivirals like Tamiflu. The identification of optimal
intervention policies means that controls, giving the existing information, account
only the relative (rather then the absolute) costs associated with the implementation
of each policy. The impact of an intervention policy based on the relative costs of in-
terventions is analyzed when the choice is either social distancing measures or access
to antiviral treatment or a combination of both (the “right” combination). Lee et
al. start from the position that the world´s limited capacity to produce an adequate
vaccine supply over a short-time horizon (a few months) must be factored in. These
authors´ research quantifies the role of restricted vaccine-level supplies in the im-
plementation of effective public health policies when cost is critical. Gonzalez-Parra
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et al identify the best ways of reducing morbidity and mortality at the population
level at a minimal relative cost. “The problem is solved by using a discrete version
of Pontryagin´s maximum principle.” Numerical results are used to highlight that
the use of dual rather than single intervention strategies has stronger impact if the
goal is to reduce the final epidemic size.
Rios-Soto et al. step back and look at the dynamics of influenza reservoirs. These
researchers focus on the interactions between transient and resident bird popula-
tions (a key genetic human-influenza reservoir) in order to throw some light on the
role of the dispersal on avian influenza dynamics. Rios-Soto et al. show that mixing
between residents and migratory bird populations and residence times (driven by
migratory patterns) play a critical role on the patterns of avian influenza spread.
Acun˜a-Soto et al. provide an epidemiological historical account of the 1918 in-
fluenza pandemic in relation to the recent 2009 H1N1 influenza pandemic. Their
detailed chronological description of the 2009 H1N1 influenza pandemic in Mexico
focuses on the detection of severe respiratory disease among young adults in central
Mexico. This description is followed by an account of the efforts carried out by
Mexican epidemiologists to identify a novel swine-origin influenza virus as well as
the response of Mexican public health authorities. Potential similarities between
the 1918-1920 and 2009 H1N1 influenza pandemics in Mexico are also addressed.
Carlos Castillo-Chavez and Gerardo Chowell-Puente
Tempe, Arizona, USA
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